Heme Oxygenase-1-Modified BMMSCs Activate AMPK-Nrf2-FTH1 to Reduce Severe Steatotic Liver Ischemia-Reperfusion Injury. Tian X, Wang Y, Yuan M, Zheng W, et al. Dig Dis Sci 2023;68:4196-4211.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tian X, Wang Y, Yuan M, Zheng W, et al. Heme Oxygenase-1-Modified BMMSCs Activate AMPK-Nrf2-FTH1 to Reduce Severe Steatotic Liver Ischemia-Reperfusion Injury. Dig Dis Sci 2023;68:4196-4211.
PMID: 37707747